# Travatan Z

NDC: 0078-0946
Generic name: travoprost
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION/ DROPS
Routes: OPHTHALMIC
Marketing started: 20061020
Marketing ended: 20261031
FDA application: NDA021994

## Active ingredients

- TRAVOPROST: .04 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-0946"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-0946
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=028455e0-ae77-4213-8819-3b58ef7d6a14